1-4 of 4
Evaren E. Page
Close
Sort by
Journal Articles

Quinine-Induced Thrombotic Microangiopathy (Q-TMA): Frequency, Presenting Features, Outcomes

Evaren E Page, MPH, Sara K. Vesely, PhD, James N. George, MD
Journal: Blood
Blood (2016) 128 (22): 1381.
https://doi.org/10.1182/blood.V128.22.1381.1381
Published: 2016
Journal Articles

Clinical importance of ADAMTS13 activity during remission in patients with acquired thrombotic thrombocytopenic purpura

Clinical Trials & Observations
Evaren E. Page, Johanna A. Kremer Hovinga, Deirdra R. Terrell, Sara K. Vesely, James N. George
Journal: Blood
Blood (2016) 128 (17): 2175–2178.
https://doi.org/10.1182/blood-2016-06-724161
Published: 2016
Includes: Supplemental data
Journal Articles

Rituximab reduces risk for relapse in patients with thrombotic thrombocytopenic purpura

Clinical Trials & Observations
Evaren E. Page, Johanna A. Kremer Hovinga, Deirdra R. Terrell, Sara K. Vesely, James N. George
Journal: Blood
Blood (2016) 127 (24): 3092–3094.
https://doi.org/10.1182/blood-2016-03-703827
Published: 2016
Journal Articles

Thrombotic Microangiopathy (TMA) and Other Severe Systemic Reactions Caused By Quinine-Containing Beverages: Report of a Patient and Review of Published Reports

Jordan M Morton, MD, Evaren E Page, MPH, Nathan W Liles, MD MPH, James N. George, MD
Journal: Blood
Blood (2015) 126 (23): 4651.
https://doi.org/10.1182/blood.V126.23.4651.4651
Published: 2015